Craft

Theradiag

Revenue

€12.2 M

FY, 2022

Theradiag Summary

Company Summary

Overview
Theradiag is a company specializing in in vitro diagnostics and theranostics, with a focus on autoimmune diseases and biotherapy monitoring. It develops, manufactures, and markets diagnostic kits for clinicians and patients and is expanding its offerings to support monitoring in areas such as infectious diseases, cancer, and innovative oncogenetic diagnostics.
Type
Subsidiary
Status
Closed
Founded
1990
HQ
Croissy-Beaubourg, FR | view all locations
Website
http://www.theradiag.com/en/
Cybersecurity rating
Sectors

Key People

  • Christian Policard

    Christian Policard, Chairman

    • Simon Daviere
    • Larry Abensur

      Larry Abensur, Director

      • Sylvain Lecomte

        Sylvain Lecomte, IVD & Services Business Unit Director

      LocationsView all

      1 location detected

      • Croissy-Beaubourg, Île-de-France HQ

        France

        14 Rue Ambroise Croizat

      Theradiag Financials

      Summary Financials

      Revenue (H1, 2023)
      €6.7M
      Gross profit (H1, 2023)
      €5.7M
      Net income (H1, 2023)
      €853.0K
      Cash (H1, 2023)
      €5.7M
      EBIT (H1, 2023)
      €768.0K

      Footer menu